MedTrace Logo

An Investigation of the Effects of Opioid Receptor Blockade on Changes in Self-esteem and Social Attention

NCT04757506 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2021-02-18

No results posted yet for this study

Summary

The purpose of this study is to explore the effects of endogenous opioids on self-esteem and attentional bias toward social cues. This is achieved by administering the drug naltrexone, which temporarily decreases endogenous opioid activity.

Conditions

  • Self Esteem

Interventions

DRUG

Naltrexone

opioid receptor antagonist

DRUG

Placebo

Sponsors & Collaborators

Principal Investigators

  • Jennifer Bartz, PhD · McGill University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-07-09
Primary Completion
2013-03-15
Completion
2013-03-15

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04757506 on ClinicalTrials.gov